New GPMed President By Anna Jurczynska | May 22, 2017 Posted in Recent News and tagged AstraZeneca, austria, Austrian society for Pharmaceutical Medicine, Bayer, Christian Baumgartner, GPMed, Wolfgang Bonitz ← Communication@EMA – how are we doing?DEVELOPMENT OF PHARMACEUTICAL MEDICINE IN IRELAND →